Emma Andrus, Editor

Click here to answer our poll.

This review of the latest dermatologic studies includes insights into immunomodulatory effects of photodynamic therapy for skin cancer, in vivo and ex vivo sonographic evaluation of tumor margins, and more.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

The NEA’s Sam Iannotti, MPH, discusses how the Seal of Acceptance helps patients and clinicians identify products that meet rigorous eczema care standards.

World Skin Health Day 2025 unites global leaders to advocate for skin health equity, emphasizing the urgent need for accessible dermatological care worldwide.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Test your knowledge of key words and terms associated with dermatology news from the previous week.

New 16-week data from the phase 2 APEX clinical trial demonstrated the anti-IL-13 antibody's efficacy across all key endpoints.

Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series!

This review of the latest dermatologic studies includes insights into effectiveness and cost-effectiveness of treatments for psoriasis, bubble hair deformity induced by bathroom heating lamp, and more.

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Explore the top headlines of the month, including insights on regulatory updates, expert pearls, and more.

The FDA has accepted for review Allergan Aesthetics' sPMA for SKINVIVE by Juvéderm, seeking approval to treat neck lines.

Unlock exclusive insights from SDPA 2025 and get expert pearls, emerging data, and clinical strategies at your fingertips. Share with us to access the full recap.

Catch up on coverage from the fourth and final day of the 2025 SDPA Annual Summer Dermatology Conference held in Washington, DC.

Expert our review of the top pearls, clinical strategies, and practice-changing tips from leading voices in dermatology at SDPA’s 2025 Summer Conference.

Test your knowledge of key words, terms, and pearls associated with this weekend's SDPA Annual Summer Dermatology Conference.

From JAK inhibitors to trichoscopy and contact allergy clues, experts at SDPA 2025 shared their top clinical pearls for managing alopecia and hair loss.

A poster from SDPA 2025 showed brodalumab maintains a consistent safety profile with no completed suicides and low infection rates.

Eileen Cheever, MPAS, PA-C, highlights the growing role of JAK inhibitors in dermatology, including emerging data on prurigo nodularis and adolescent alopecia areata.

Maria Hordinsky, MD, urges dermatology clinicians to consider allergic contact dermatitis when scarring alopecia treatments fail.

Catch up on coverage from the third day of the 2025 SDPA Annual Summer Dermatology Conference held in Washington, DC.

At SDPA 2025, a poster evaluating the STRATUM trial showed roflumilast foam 0.3% effectively treats seborrheic dermatitis with minimal pigment changes.

David Cotter, MD, PhD, discusses diagnosing alopecia areata and selecting systemic treatments, including JAK inhibitors, from his SDPA 2025 presentation.

Amy Spizuoco, DO, FAOCD, shared how trichoscopy enhances alopecia evaluation by improving diagnostic speed, accuracy, and reducing biopsy need.

Nearly all injection site reactions among patients in the ARCADIA 1/2 and OLYMPIA 1/2 clinical trials were mild and transient in nature.

Ongoing maintenance therapy is essential to avoid relapse and preserve gains in repigmentation for patients with vitiligo, according to Gina Mangin, MPAS, PA-C.

Orit Markowitz, MD, shares how a color-focused strategy helps spot early malignancies—even 2-mm lesions—across all skin tones.

A yearlong study showed dupilumab alone effectively prevented flares in moderate to severe atopic dermatitis, with consistent safety across various dosing schedules.